We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Merck & Co., Inc. stands seventh on our list and recently ...

Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its best-selling cancer drug Keytruda to the U.S. and speed future medicines to market.

On July 9, Merck announced that it would acquire Verona Pharma, a U.K.-based biotechnology company specializing in the ...

Merck (NYSE:MRK) has broken ground on a $1 billion facility in Wilmington, Delaware, becoming the latest pharmaceutical company to boost domestic investment as industry-targeted tariffs loom.

Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware Apr. 29, 2025 6:45 AM ET Merck & Co., Inc. (MRK) Q1: 2025-04-24 Earnings Summary ...

Merck & Co., Inc. is acquiring Verona Pharma plc for $10bn to bolster long-term growth with COPD drug Ohtuvayre. Click for my updated look at MRK and VRNA stock.

“Merck’s massive expansion in De Soto further elevates Kansas’ long-established status as a global leader in animal health,” Lieutenant Governor and Secretary of Commerce David Toland said.